 |
|
Atrial fibrillation and chronic kidney disease: A bad combination
Márcio Galindo Kiuchi
Kidney Res Clin Pract. 2018;37(2):103-105. Published online 2018 Jun 30 DOI: https://doi.org/10.23876/j.krcp.2018.37.2.103
|
|
Citations to this article as recorded by
 Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis
Ioannis Kyriakoulis, Anastasia Adamou, Iliana Stamatiou, David Dimitris Chlorogiannis, Ioannis Kardoutsos, Despoina Koukousaki, George Ntaios
European Journal of Internal Medicine.2024; 119: 45. CrossRef Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink
Natasha Slater, Simon White, Martin Frisher
Journal of Arrhythmia.2024; 40(1): 47. CrossRef Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study
Kyung-Yeon Lee, So-Ryoung Lee, Eue-Keun Choi, JungMin Choi, Hyo-Jeong Ahn, Soonil Kwon, Bongseong Kim, Kyung-Do Han, Seil Oh, Gregory Y. H. Lip
Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients
Eva Pella, Afroditi Boutou, Aristi Boulmpou, Marieta P. Theodorakopoulou, Artemios G. Karagiannidis, Nasra Haddad, Fotini Iatridi, Ioannis Tsouchnikas, Christodoulos E. Papadopoulos, Vassilios Vassilikos, Pantelis A. Sarafidis
International Urology and Nephrology.2024; 57(3): 897. CrossRef Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management
Bharat Sidhu, Akash Mavilakandy, Katherine L. Hull, Ivelin Koev, Zakariyya Vali, James O. Burton, G. André Ng
Reviews in Cardiovascular Medicine.2024;[Epub] CrossRef Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population‐Based Study
Seon‐Mi Kim, Yujin Jeong, Yae Lim Kim, Minjung Kang, Eunjeong Kang, Hyunjin Ryu, Yunmi Kim, Seung Seok Han, Curie Ahn, Kook‐Hwan Oh
Journal of the American Heart Association.2023;[Epub] CrossRef Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
Dolina Gencheva
Journal of Cardiovascular Emergencies.2023; 9(3): 49. CrossRef Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis
Ido Zamberg, Marie Assouline-Reinmann, Emmanuel Carrera, Manish M Sood, Stephen M Sozio, Pierre-Yves Martin, Thomas A Mavrakanas
Nephrology Dialysis Transplantation.2022; 37(7): 1289. CrossRef Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant
Ahsan A. Khan, Lewis J. Hardy, Eduard Shantsila, Yee C. Lau, Helen Philippou, Gregory Y.H. Lip
Thrombosis Research.2021; 197: 69. CrossRef Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: A meta‐analysis
Wei‐Chieh Lee, Po‐Jui Wu, Chih‐Yuan Fang, Huang‐Chung Chen, Mien‐Cheng Chen
International Journal of Clinical Practice.2021;[Epub] CrossRef Dialysis Mode and Associated Outcomes in Patients With End‐Stage Renal Disease and Atrial Fibrillation: A 14‐Year Nationwide Cohort Study
Chih‐Hsiang Chang, Pei‐Chun Fan, Yu‐Sheng Lin, Shao‐Wei Chen, Michael Wu, Ming‐Shyan Lin, Cheng‐Hui Lu, Po‐Cheng Chang, Ming‐Jer Hsieh, Chao‐Yung Wang, Chun‐Li Wang, Pao‐Hsien Chu, Victor Chien‐Chia Wu
Journal of the American Heart Association.2021;[Epub] CrossRef Dose discordance of direct acting oral anticoagulants using different equations for estimating GFR: a literature review
Morteza Nabiee, Simin Dashti-Khavidaki, Behrouz Khajeh
Expert Review of Clinical Pharmacology.2020; 13(8): 857. CrossRef TO DETERMINE THE ROLE OF RANOLAZINE FOR RHYTHM CONTROL STRATEGY IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION- AN OBSERVATIONAL STUDY FROM A TERTIARY CARE CENTER. (RANOVA STUDY)
Praveen Shukla, Awadhesh Kumar Sharma, Biswajit Majumder, Pritam Kumar Chatterjee, Vinay Krishna, Anamika Shukla
GLOBAL JOURNAL FOR RESEARCH ANALYSIS.2020; : 48. CrossRef Safety of dabigatran in patients with atrial fibrillation and chronic kidney disease: pharmacokinetic and pharmacogenetic aspects
A. I. Skripka, P. O. Bochkov, K. A. Akmalova, R. V. Shevchenko, P. M. Krupenin, V. V. Kogay, A. I. Listratov, A. S. Krainyaya, D. A. Napalkov, O. S. Gurinovich, A. A. Sokolova, V. V. Fomin, D. A. Sychev
Medical Council.2020; (21): 65. CrossRef Approaches for the identification of chronic kidney disease in CPRD–HES-linked studies
Sreeram Ramagopalan, Thomas P Leahy, Elaine Stamp, Cormac Sammon
Journal of Comparative Effectiveness Research.2020; 9(7): 441. CrossRef Genome-wide screening of functional long noncoding RNAs in the epicardial adipose tissues of atrial fibrillation
Xin Shi, Xuelian Shao, Ban Liu, Mengwei Lv, Pratik Pandey, Changfa Guo, Ruilin Zhang, Yangyang Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(7): 165757. CrossRef Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease
Alena Skripka, Dmitriy Sychev, Pavel Bochkov, Roman Shevchenko, Pavel Krupenin, Veronika Kogay, Alexander Listratov, Arina Krainyaya, Olga Gurinovich, Anastasiya Sokolova, Dmitry Napalkov, Viktor Fomin
High Blood Pressure & Cardiovascular Prevention.2020; 27(2): 151. CrossRef Prevalence of Advanced Chronic Kidney Disease in Patients with Nonvalvular Atrial Fibrillation Hospitalized in Cardiology Departments
M. I. Chashkina, N. L. Kozlovskaya, D. A. Andreev, N. A. Ananicheva, A. A. Bykova, Z. K. Salpagarova, A. L. Syrkin
Kardiologiia.2020; 60(2): 41. CrossRef Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients
Marius Miglinas, Ugne Cesniene, Marta Monika Janusaite, Arturas Vinikovas
Frontiers in Cardiovascular Medicine.2020;[Epub] CrossRef
|